马克斯城的收入在2025年下降了15%,但最终拥有1.556亿美元现金,并预计将在2026年增长. MaxCyte revenue dropped 15% in 2025 but ended with $155.6 million cash and expects growth in 2026.

根据MaxCyte的报道,由于主要客户减少购买和停止SPL计划,其收入在2025年下降了15%,达到3300万美元. MaxCyte reported a 15% revenue drop to $33 million in 2025, driven by a major customer's reduced purchases and discontinued SPL programs. 公司在年底收盘时,现金为1.556亿美元,没有任何债务. However, the company ended the year with $155.6 million in cash and no debt. 展望未来,首席执行官马赫尔·马苏德强调了新的支出轨迹,大幅减少现金消耗以及即将推出的Xpert DTX系统作为预计在2026年推动有意义的收入增长的因素. Looking ahead, CEO Maher Masoud highlighted a new spending trajectory, a significant reduction in cash burn, and the upcoming launch of the Xpert DTX system as factors expected to drive meaningful revenue growth in 2026.